Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vildagliptin Add-on vs Metformin Up-titration in Chinese T2D
NCT01541956Phase 4Completed
- Sponsor
- Novartis
- Start
- Feb 2012
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of vildagliptin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Novartis. Primary endpoint: Change from baseline in hemoglobin A1c at 24 weeks. Started Feb 2012; status: completed.
02
Drugs
vildagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01541956.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01541956.